by Kraneshares
Access the next global megatrend through the KraneShares Global Humanoid & Embodied Intelligence Index ETF (ticker: KOID)
KOID
3/31/2026
![]()
KOID seeks to track the MerQube Global Humanoid and Embodied Intelligence Index, which is designed to capture the performance of companies engaged in humanoid and embodied intelligence-related business. The underlying index focuses on key categories within the humanoid and embodied intelligence ecosystem, including the companies that design and manufacture humanoid robots and their supply chains that provide key components for humanoids and embodied intelligence.
![]()
![]()
Unitree G1 Ultimate Unitree's state-of-the-art humanoid robot.
Tesla Optimus Gen3 Targeted for manufacturing and domestic chores, aiming to replace repetitive or hazardous labor.
1X Neo Gamma Organizes dishes, vacuums, and brews tea using NVIDIA's Isaac GR00T N1 AI for real-time sensor processing.
Figure 03 Deployed at BMW's Spartanburg factory for assembly tasks, leveraging NVIDIA's AI for vision and decision-making.
UBTech Walker S Actively used in Audi, BYD, and Geely factories for tasks like quality inspections, material handling (15 kg payload), and collaborative sorting.
AGIBOT X2 Series Deployed in leading automotive and electronics plants for precision assembly, palletizing, and safe human-robot collaboration.
![]()
March 18, 2025
FIGURE 01 + OPENAI — SPEECH-TO-SPEECH REASONING
![]()
Morgan Stanley projects that the global humanoid total addressable market could reach nearly $5 trillion by 2050
Annual Humanoid Revenue ($bn): 0, 3, 4, 6, 11, 24, 24, 67, 84, 97, 117, 211, 280, 459, 638, 886, 1216, 1622, 1994, 2418, 2750, 3172, 3510, 4001, 4254, 4621, 4703 (2024–2050e)
![]()
| Company | Country | Approximate Units Shipped |
|---|---|---|
| Unitree | China | ~5,500 |
| AgiBot | China | ~5,100 |
| UBTech | China | ~1,000 |
| Leju Robotics | China | ~500 |
| Engine AI | China | ~400 |
| Fourier Intelligence | China | ~300 |
| Figure AI | United States | ~150 |
| Agility Robotics | United States | ~150 |
| Tesla | United States | ~150 |
| Other | — | ~1,300 |
![]()
Factories: By 2030, humanoid robots could replace up to 20 million production jobs globally, with major deployments already underway in automotive factories, where robots assemble components and perform repetitive or hazardous tasks.
Hospitals: The medical service robotics market is projected to grow to $21 billion by 2028, as robots increasingly assist with patient care, physical therapy, monitoring, and improving accessibility for people with disabilities.
Homes: We believe domestic humanoid robots are expected to become mainstream by 2030, handling household chores such as cleaning, laundry, and dishwashing, and providing personalized care for the elderly and individuals with chronic illnesses.
![]()
![]()
Actuation and Mechanical Systems account for ~55% of total cost of a humanoid
Actuation systems provide the "muscles" of humanoid robots, enabling precise movement and force control. This category includes components critical for joint articulation, energy efficiency, and compact design. Precision here determines agility and energy efficiency.
Mechanical components form the structural foundation of humanoids, ensuring durability, weight optimization, and smooth motion transmission. Mechanical reliability ensures humanoids operate safely in dynamic environments.
Sensing & Perception Systems account for ~15% of total cost of a humanoid
Sensors and perception systems allow humanoids to interpret their environment, enabling tasks like navigation, object manipulation, and human interaction. Sensor fusion (combining LiDAR, tactile, and vision data) is critical for embodied intelligence decision-making.
Companies supply critical materials for high-performance motors and humanoid manufacturing.
Intelligence Systems account for ~23% of total cost of a humanoid
This category provides the computational backbone for humanoid and embodied intelligence, motor control, and sensor processing.
Companies in this category focus on designing, assembling, and commercializing complete humanoid robots.
![]()
![]()
Initial company will be selected based on company's free-float market cap, trading volume, etc. Retain companies that have a minimum market cap of $1 billion and daily traded value of $1 million
Each company will be filtered by industry. Trimmed down to Humanoid and Embodied Intelligence related industries
Companies receive evaluation scores derived from corporate filings, media coverage, and publicly available data regarding their direct participation in Humanoid and Embodied Intelligence technologies or their strategic supply chain partnerships with established humanoid robotics firms. Top ranking companies are selected for inclusion in the index.
Equal Weighted Rebalanced quarterly
![]()
Actuation and Mechanical Systems account for ~55% of total cost of a humanoid*
Sensing and Perception Systems account for ~15% of total cost of a humanoid*
Intelligence Systems account for ~23% of total cost of a humanoid*
![]()
| Category | Company | Description |
|---|---|---|
| Actuation Systems | Tuopu | Core supplier of Tesla's Optimus, specializing in integrated motor, reducer, and controller systems |
| Sanhua | Sanhua specializes in bionic robot electromechanical actuators, with particular emphasis on hollow cup motors and harmonic drives used in rotary actuators. Core supplier of Tesla's Optimus. | |
| Novanta | Supplies optical/magnetic encoders for real-time position feedback in humanoid joints, enabling precise motion calibration. | |
| Mechanical Systems | Leader Drive | Major global manufacturer of humanoid robot precision reducers, essential for converting motor motion and enabling precise, coordinated movement in robotic joints. |
| Shuanghuan | Supplies planetary gear systems for humanoid wrist actuators, enhancing grip strength. | |
| Amphenol | Designs high-speed data connectors for real-time sensor fusion in humanoid perception systems. | |
| Sensing & Perception | Keli Sensing | Produces 6-axis force/torque sensors for humanoid feet/hands, enabling adaptive grip and balance. |
| Sensata | Develops MEMS-based tactile sensors for humanoid fingertips, critical for object manipulation. | |
| Teledyne | Supplies thermal imaging cameras for humanoids operating in low-light conditions. | |
| Critical Material | MP Materials | Supplies neodymium magnets for high-performance motors, essential for miniaturized actuators in humanoids. |
| Lynas Rare Earths | Major global supplier of rare-earth elements for permanent magnets in humanoid robotics motors. | |
| Semiconductors & Technology | Nvidia | Provides Isaac GR00T N1 foundation model for robot reasoning + Newton physics engine (with Google/Disney) for movement simulation. Powers 1X's household robots and Disney's BDX droids. |
| Horizon Robotics | Designs energy-efficient AI chips (e.g., Journey 5) for humanoid edge computing, targeting consumer-facing robots. | |
| Humanoid Integration & Manufacturing | Tesla | Developing Optimus Gen 3 humanoid robot with 22-degree-of-freedom hands, targeting production of 5,000-12,000 units by end of 2025 |
| Xpeng | Operates "Iron" humanoid robot with 60 joints, 200 degrees of freedom, and 3,000 TOPS processing power, powered by proprietary Turing AI chips |
![]()
On March 20th, 2026, the Shanghai Stock Exchange formally accepted Unitree Robotics' IPO application for the STAR Market.
Unitree's IPO is important to KOID's opportunity set in several ways:
It expands the investable universe of "integrator" companies, particularly within China's onshore market, complementing existing exposures to global humanoid and embodied intelligence leaders.
It provides an additional public market benchmark for valuing high-growth humanoid robotics firms, which can influence sentiment and pricing across the ecosystem KOID targets.
Unitree's heavy domestic sourcing and vertical integration spotlight the importance of core component suppliers, motors, reducers, sensors, and controllers, that already represent a meaningful weight in the KOID portfolio (~74%).
![]()
![]()
KOID seeks to track the MerQube Global Humanoid and Embodied Intelligence Index, which is designed to capture the performance of companies engaged in humanoid and embodied intelligence-related business. The underlying index focuses on key categories within the humanoid and embodied intelligence ecosystem, including the companies that design and manufacture humanoid robots and their supply chains that provide key components for humanoids and embodied intelligence.
| Detail | Value |
|---|---|
| Primary Exchange | NASDAQ |
| CUSIP | 500767751 |
| ISIN | US5007677512 |
| Total Annual Fund Operating Expense (Gross) | 0.79% |
| Total Annual Fund Operating Expense (Net)* | 0.69% |
| Inception Date | 06/04/2025 |
| Distribution Frequency | Annual |
| Underlying Index | MerQube Global Humanoid and Embodied Intelligence Index |
| Net Assets | $119,175,183 |
| Number of Holdings | 59 |
| Company | Ticker | % |
|---|---|---|
| JABIL INC | JBL | 2.13 |
| CREDO TECHNOLOGY GROUP HOLDI | CRDO | 2.12 |
| AMPHENOL CORP-CL A | APH | 2.10 |
| MP MATERIALS CORP | MP | 2.10 |
| NVIDIA CORP | NVDA | 2.09 |
| SENSATA TECHNOLOGIES HOLDING | ST | 2.09 |
| TE CONNECTIVITY PLC | TEL | 2.09 |
| REGAL REXNORD CORP | RRX | 2.08 |
| NXP SEMICONDUCTORS NV | NXPI | 2.08 |
| ANALOG DEVICES INC | ADI | 2.08 |
| 3 Mo | 6 Mo | Since Inception | |
|---|---|---|---|
| Fund NAV | -3.63% | -3.55% | 23.31% |
| Closing Price | -2.04% | -1.90% | 25.88% |
| Underlying Index | -3.97% | -4.02% | 22.46% |
![]()
Empowering investors with access to the world's most powerful growth themes through ETFs, private strategies, and innovative investment solutions.
![]()
Strategy also available in UCITS / ETC
![]()
Total Addressable Market (TAM): The Total Addressable Market (TAM) is a measure of the total revenue opportunity available for a product or service if it achieved 100% market share.
Compound Annual Growth Rate (CAGR): Compound annual growth rate is a business, economics, and investing term representing the mean annualized growth rate for compounding values over a given time period.
![]()
Important Notes:
Carefully consider the Funds' investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Funds' full and summary prospectus, which may be obtained by visiting www.kraneshares.com/koid. Read the prospectus carefully before investing.
Investing involves risk, including possible loss of principal. There can be no assurance that a Fund will achieve its stated objectives. Indices are unmanaged and do not include the effect of fees. One cannot invest directly in an index.
This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change.
Humanoid and embedded intelligence technology companies often face high research and capital costs, resulting in variable profitability in a competitive market where products can quickly become obsolete. Their reliance on intellectual property makes them vulnerable to losses, while legal and regulatory changes can impact profitability.
A-Shares are issued by companies in mainland China and traded on local exchanges. They are available to domestic and certain foreign investors, including QFIs and those participating in Stock Connect Programs like Shanghai-Hong Kong and Shenzhen-Hong Kong. Foreign investments in A-Shares face various regulations and restrictions, including limits on asset repatriation.
The Japanese economy depends heavily on international trade and is vulnerable to economic, political, and social instability, which could affect the Fund. The yen is volatile, influenced by fluctuations in Asia, and has historically shown unpredictable movements against the U.S. dollar.
The Fund invests in non-U.S. securities, which can be less liquid and subject to weaker regulatory oversight compared to U.S. securities. Risks include currency fluctuations, political or economic instability, incomplete financial disclosure, and potential taxes or nationalization of holdings.
![]()
The Fund may invest in derivatives, which are often more volatile than other investments and may magnify the Fund's gains or losses. A derivative (i.e., futures/forward contracts, swaps, and options) is a contract that derives its value from the performance of an underlying asset. The primary risk of derivatives is that changes in the asset's market value and the derivative may not be proportionate, and some derivatives can have the potential for unlimited losses. Derivatives are also subject to liquidity and counterparty risk.
Large capitalization companies may struggle to adapt fast, impacting their growth compared to smaller firms, especially in expansive times. This could result in lower stock returns than investing in smaller and mid-sized companies. In addition to the normal risks associated with investing, investments in smaller companies typically exhibit higher volatility.
A large number of shares of the Fund is held by a single shareholder or a small group of shareholders. Redemptions from these shareholders can harm Fund performance, especially in declining markets, leading to forced sales at disadvantageous prices, increased costs, and adverse tax effects for remaining shareholders.
The Fund is new and does not yet have a significant number of shares outstanding. If the Fund does not grow in size, it will be at greater risk than larger funds of wider bid-ask spreads for its shares, trading at a greater premium or discount to NAV, liquidation and/or a trading halt. Narrowly focused investments typically exhibit higher volatility. KOID is non-diversified.
Neither MerQube, Inc. nor any of its affiliates (collectively, "MerQube") is the issuer or producer of KOID and MerQube has no duties, responsibilities, or obligations to investors in KOID. The index underlying the KOID is a product of MerQube and has been licensed for use by Krane Funds Advisors, LLC and its affiliates. MerQube® is a registered trademark of MerQube, Inc.
The MerQube Global Humanoid and Embodied Intelligence Index is determined, composed and calculated by MerQube without regard to Krane Funds Advisors, LLC and its affiliates or the KOID. There is no assurance that investment products based on the MerQube Global Humanoid and Embodied Intelligence Index will accurately track index performance or provide positive investment returns. MerQube is not an investment advisor.
![]()
NEITHER MERQUBE NOR ANY OTHER DATA PROVIDER GUARANTEES THE ADEQUACY, ACCURACY, TIMELINESS AND/OR THE COMPLETENESS OF THE MERQUBE GLOBAL HUMANOID AND EMBODIED INTELLIGENCE INDEX OR ANY DATA RELATED THERETO (INCLUDING DATA INPUTS) OR ANY COMMUNICATION WITH RESPECT THERETO. NEITHER MERQUBE NOR ANY OTHER DATA PROVIDERS SHALL BE SUBJECT TO ANY DAMAGES OR LIABILITY FOR ANY ERRORS, OMISSIONS, OR DELAYS THEREIN. MERQUBE AND ITS DATA PROVIDERS MAKE NO EXPRESS OR IMPLIED WARRANTIES, AND THEY EXPRESSLY DISCLAIM ALL WARRANTIES, OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE OR AS TO RESULTS TO BE OBTAINED BY KRANE FUNDS ADVISORS, LLC AND ITS AFFILIATES, OWNERS OF THE KOID, OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE MERQUBE GLOBAL HUMANOID AND EMBODIED INTELLIGENCE INDEX OR WITH RESPECT TO ANY DATA RELATED THERETO. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT WHATSOEVER SHALL MERQUBE OR DATA PROVIDERS BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES INCLUDING BUT NOT LIMITED TO, LOSS OF PROFITS, TRADING LOSSES, LOST TIME OR GOODWILL, EVEN IF THEY HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, WHETHER IN CONTRACT, TORT, STRICT LIABILITY, OR OTHERWISE.
ETF shares are bought and sold on an exchange at market price (not NAV) and are not individually redeemed from the Fund. However, shares may be redeemed at NAV directly by certain authorized broker-dealers (Authorized Participants) in very large creation/redemption units. The returns shown do not represent the returns you would receive if you traded shares at other times. Shares may trade at a premium or discount to their NAV in the secondary market. Brokerage commissions will reduce returns. Beginning 12/23/2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn't available, the midpoint between the national best bid and national best offer ("NBBO") as of the time the ETF calculates the current NAV per share. NAVs are calculated using prices as of 4:00 PM Eastern Time.
The KraneShares ETFs and KFA Funds ETFs are distributed by SEI Investments Distribution Company (SIDCO), 1 Freedom Valley Drive, Oaks, PA 19456, which is not affiliated with Krane Funds Advisors, LLC, the Investment Adviser for the Funds, or any sub-advisers for the Funds.
![]()